1. Home
  2. EFSI vs ACHV Comparison

EFSI vs ACHV Comparison

Compare EFSI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Financial Services Inc

EFSI

Eagle Financial Services Inc

HOLD

Current Price

$39.25

Market Cap

185.5M

Sector

Finance

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$3.94

Market Cap

172.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EFSI
ACHV
Founded
1881
N/A
Country
United States
United States
Employees
231
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.5M
172.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
EFSI
ACHV
Price
$39.25
$3.94
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$41.50
$14.67
AVG Volume (30 Days)
10.3K
1.6M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$31.93
N/A
Revenue Next Year
$4.38
N/A
P/E Ratio
$24.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.70
$2.00
52 Week High
$41.12
$6.03

Technical Indicators

Market Signals
Indicator
EFSI
ACHV
Relative Strength Index (RSI) 55.36 53.11
Support Level $36.62 $4.06
Resistance Level $39.46 $4.98
Average True Range (ATR) 0.97 0.40
MACD 0.01 0.04
Stochastic Oscillator 32.72 44.09

Price Performance

Historical Comparison
EFSI
ACHV

About EFSI Eagle Financial Services Inc

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: